Page last updated: 2024-11-05

4-acetylaminobiphenyl

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID19998
CHEMBL ID300429
CHEBI ID177487
SCHEMBL ID171741
MeSH IDM0075089

Synonyms (70)

Synonym
CHEBI:177487
mfcd00276655
n-(4-phenylphenyl)acetamide
4'-phenylacetanilide
nsc3134
acetamide,1'-biphenyl]-4-yl-
n-(4-biphenylyl)acetamide
4-biphenylacetylamide
nsc-3134
n-acetyl-4-aminobiphenyl
(4-biphenyl)acetamide
n-(4-biphenyl)acetamide
4075-79-0
acetanilide, 4'-phenyl-
4-phenylacetanilide
4-acetamidobiphenyl
p-phenylacetanilide
wln: 1vmr dr
acetanilide, p-phenyl-
4-acetylaminobiphenyl
nsc227192
nsc-227192
n-biphenyl-4-ylacetamide
4-biphenylacetamide
n-4-biphenylacetamide
n-(1,1'-biphenyl)-4-ylacetamide
nsc 227192
brn 2097736
4'-fenylacetanilid [czech]
hsdb 5068
biphenyl, 4-acetamido
n-acetylxenylamin [czech]
nsc 65931
acetamide, n-(1,1'-biphenyl)-4-yl-
4-(acetylamino)biphenyl
acetamide, n-[1,1'-biphenyl]-4-yl-
nsc 3134
ai3-01431
ccris 734
nsc65931
nsc-65931
IDI1_016849
MAYBRIDGE3_005462
NCIOPEN2_002951
n-(biphenyl-4-yl)acetamide
STK396441
HMS1446I06
CHEMBL300429
AKOS000121530
C20285
n-acetylxenylamin
4'-fenylacetanilid
u9bhq2tj87 ,
unii-u9bhq2tj87
4-12-00-03248 (beilstein handbook reference)
4-acetylaminobiphenyl [hsdb]
acetylaminobiphenyl, 4-
SCHEMBL171741
4-acetamido-1,1'-biphenyl
4-acetaminobiphenyl
4-acetamido-1,1'biphenyl
n-([1,1'-biphenyl]-4-yl)acetamide
n-[1,1'-biphenyl]-4-ylacetamide #
n-(1,1'-biphenyl-4-yl)acetamide
acetamide,n-[1,1'-biphenyl]-4-yl-
DTXSID8039243
n-biphenyl-4-yl-acetamide
Z30177125
Q27290959
EN300-15554
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
biphenylsBenzenoid aromatic compounds containing two phenyl or substituted-phenyl groups which are joined together by a single bond.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (9)

Assay IDTitleYearJournalArticle
AID167955Carcinogenic activity on ear duct after oral administration1981Journal of medicinal chemistry, Mar, Volume: 24, Issue:3
Computer-assisted structure-activity studies of chemical carcinogens. Aromatic amines.
AID168099Compound was tested for carcinogenic activity on mixed data after oral administration of the compound; + denotes four or five active sites.1981Journal of medicinal chemistry, Mar, Volume: 24, Issue:3
Computer-assisted structure-activity studies of chemical carcinogens. Aromatic amines.
AID143757Inhibition of AHAT-catalyzed transacylation of 4-aminoazobenzene1983Journal of medicinal chemistry, Dec, Volume: 26, Issue:12
N-arylhydroxamic acid N,O-acyltransferase. Positional requirements for the substrate hydroxyl group.
AID167927Carcinogenic activity on all sites after oral administration1981Journal of medicinal chemistry, Mar, Volume: 24, Issue:3
Computer-assisted structure-activity studies of chemical carcinogens. Aromatic amines.
AID167939Carcinogenic activity on breast after oral administration of the compound1981Journal of medicinal chemistry, Mar, Volume: 24, Issue:3
Computer-assisted structure-activity studies of chemical carcinogens. Aromatic amines.
AID168086Compound was tested for carcinogenic activity on liver after oral administration of the compound; - denotes non carcinogenic activity.1981Journal of medicinal chemistry, Mar, Volume: 24, Issue:3
Computer-assisted structure-activity studies of chemical carcinogens. Aromatic amines.
AID168110Carcinogenic activity on other sites after oral administration1981Journal of medicinal chemistry, Mar, Volume: 24, Issue:3
Computer-assisted structure-activity studies of chemical carcinogens. Aromatic amines.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).2014Journal of biomolecular screening, Jul, Volume: 19, Issue:6
A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-19908 (61.54)18.7374
1990's3 (23.08)18.2507
2000's0 (0.00)29.6817
2010's1 (7.69)24.3611
2020's1 (7.69)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.55

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.55 (24.57)
Research Supply Index2.64 (2.92)
Research Growth Index4.19 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.55)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other13 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]